Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 9Phase 1 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 22INDUSTRY 6NIH 4NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 1Neutropenia 1Fallopian Tube Neoplasms 1Endometrial Adenosquamous Carcinoma 1Communicable Diseases 1

Interventions

Cisplatin 24Radiotherapy 18Carboplatin 18Paclitaxel 17Vincristine 15Cyclophosphamide 14Etoposide 13Filgrastim 12Doxorubicin 12Gemcitabine 11Temozolomide 10Cytarabine 9Topotecan 8Docetaxel 8Methotrexate 7Irinotecan 7Granulocyte Colony-Stimulating Factor 7Dexamethasone 7Taxes 6Radiation 6Peripheral Blood Stem Cell Transplantation 6Radiotherapy, Conformal 5Oxaliplatin 5Melphalan 5Fenretinide 5Chemotherapy, Adjuvant 5Capecitabine 5etoposide phosphate 4Trastuzumab 4Platinum 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × pegfilgrastim × Clear all
NCT00575952 2017-08-24

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

GOG Foundation

Phase 1 Completed
27 enrolled
Gynecologic

Endometrial Adenosquamous Carcinoma

NCT00352300 2014-12-31

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

GOG Foundation

Phase 1 Completed
43 enrolled
Gynecologic

Communicable Diseases, Fallopian Tube Neoplasms, Neutropenia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡